HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

V A Burkovskaia Selected Research

1-phenyl-2,3-dimethyl-4-iodopyrazolone

1/2005[Combined treatment with reaferon and iodantipirin in patients with chronic viral hepatitides B and C].

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


V A Burkovskaia Research Topics

Disease

3Chronic Obstructive Pulmonary Disease (COPD)
01/2012 - 01/2009
2Body Weight (Weight, Body)
01/2010 - 01/2009
2Hepatitis
01/2007 - 01/2005
2Chronic Hepatitis B
01/2005 - 01/2003
1Inflammatory Bowel Diseases (Inflammatory Bowel Disease)
07/2010
1Ulcerative Colitis
01/2010
1Malabsorption Syndromes (Malabsorption Syndrome)
01/2010
1Cachexia
01/2009
1Necrosis
01/2009
1Fibrosis (Cirrhosis)
01/2007
1Chronic Hepatitis (Chronic Active Hepatitis)
01/2005

Drug/Important Bio-Agent (IBA)

3Proteins (Proteins, Gene)FDA Link
01/2012 - 01/2009
2FatsIBA
01/2012 - 01/2009
2CarbohydratesIBA
07/2010 - 01/2009
2EnzymesIBA
01/2010 - 01/2009
1Hormones (Hormone)IBA
01/2010
1Monoclonal AntibodiesIBA
01/2010
1Fatty Acids (Saturated Fatty Acids)IBA
01/2010
1LeptinIBA
01/2010
1Xylose (D-Xylose)FDA Link
01/2009
1AlbuminsIBA
01/2009
1Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
01/2009
1Radioisotopes (Radionuclides)IBA
01/2009
1Hydroxyproline (4 Hydroxyproline)IBA
01/2007
1Biomarkers (Surrogate Marker)IBA
01/2007
1Collagenases (Collagenase)FDA Link
01/2007
1Fibronectins (Fibronectin)IBA
01/2007
1CollagenIBA
01/2007
1Interferon alpha-2 (Roferon-A)FDA Link
01/2005
1AntioxidantsIBA
01/2005
11-phenyl-2,3-dimethyl-4-iodopyrazoloneIBA
01/2005
1Lipid Bilayers (Lipid Bilayer)IBA
01/2003
1LipidsIBA
01/2003

Therapy/Procedure

1Therapeutics
01/2005